glp-1-receptoragonister GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Evolution of GLP‐1 Receptor Agonists

[DOI] [PubMed] [Google Scholar] 25.Matthews J.E., Stewart M.W., De Boever E.H., Dobbins R.L., Hodge R.J., Walker S.E

A recent meta-analysis proposed K-18 values between 127191 U l 1 for ruling-out MASH at fixed sensitivity levels and 304399 U l 1 to rule-in MASH at fixed specificity levels 32

17 Similar findings have been reported in analyses of subjects who underwent metabolic surgery compared with those who did not

First published

That evidence may matter significantly for patients with: Prior heart attack Stroke history Significant cardiovascular risk factors Patients Who Prefer Weekly Rather Than Daily Dosing Some people are actually more consistent with once-weekly routines than with daily medications

Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which typically diminish over time